AcademiaAdvance research and accelerate real-world outcomes
Advance research and accelerate real-world outcomes
CorporateDrive innovation and build strong brands
Drive innovation and build strong brands
GovernmentMaximize the impact of your country’s research and innovation
Maximize the impact of your country’s research and innovation
Legal ServicesEvolve your practice and maximize growth potential
Evolve your practice and maximize growth potential
Life Sciences and HealthcareAdvance innovation and accelerate patient outcomes
Advance innovation and accelerate patient outcomes
Scientific & Academic Researcharrow_forward
Discovery & Workflow
Analytics, Evaluation & Management
Libraries, Teaching & Learning
Research & Development
Pharmacovigilance & Drug Safety
Regulatory & Compliance
Portfolio Strategy & Business Development
Commercial & Launch Strategy
Generics & Manufacturing
Strategic Portfolio Planning
Product Lifecycle Management
IP Litigation Intelligence Solutions
Patent Intelligence Software
Patent Search & Analytics
Trademark Research & Protection
Chemistry & Life Science
IP Data & APIs
IP Lifecycle Managementarrow_forward
IP Management Software
Network Collaboration Tools
Patent & Trademark Maintenance
Filing & Prosecution Support
Patent Translations Services
Consulting & Dataarrow_forward
Data integration and custom analytics
Real World Data
BlogKeep up with the latest news, insights and research from Clarivate.
Keep up with the latest news, insights and research from Clarivate.
Clarivate Innovation ExchangeThe Clarivate Innovation Exchange accelerates research, development and commercialization.
The Clarivate Innovation Exchange accelerates research, development and commercialization.
Partnersarrow_forwardPartner with us and help accelerate innovation.
Partner with us and help accelerate innovation.
Channel Partner Program
Cortellis Partner Program
ScholarOne Partner Program
Researcher RecognitionWorld-changing research should be seen, shared and celebrated.
World-changing research should be seen, shared and celebrated.
Academic & Government
Life Sciences & Healthcare
Reports & Case Studiesarrow_forward
ISI Global Research Reports
PodcastsThe Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
The Clarivate podcast series enables us to address issues in key business areas in new and interesting ways.
Life Sciences and Healthcare
Scientific & Academic Research
IP Lifecycle Management
Consulting & Data
Clarivate Innovation Exchange
Reports & Case Studies
New Hema Text
Pre-exposure prophylaxis (PrEP) is a key prevention strategy for ending the human immunodeficiency virus (HIV) epidemic. The FDA’s approval of Gilead’s Truvada in 2012 and Descovy in 2019…
Non-small-cell lung cancer (NSCLC)—the leading cause of cancer-related deaths in China—has a highly dynamic drug development pipeline, including several targeted and biomarker-driven therapies…
The asthma therapy market consists of many well-established treatments, including inhaled agents (e.g., GlaxoSmithKline’s Advair / Seretide, AstraZeneca’s Symbicort, Boehringer Ingelheim’s…
The treatment landscape for squamous cell carcinoma of the head and neck (SCCHN) witnessed a major change in 2019 with the approval of Merck & Co.’s Keytruda for untreated recurrent or metastatic…
Clarivate expects the next 10 years to be transitional for patients with hemophilia A (with and without inhibitors) owing to the entry of several novel therapeutic options into the market. With the…